Acura Pharma Cash Flow - Quarterly (OTCMKTS:ACUR)

Add to My Stocks
$0.4 $0 (0%) ACUR stock closing price Jun 22, 2018 (Closing)

The Acura Pharma cash flow statement helps investors understand how well the company is managing its cash flows. This statement shows details about the cash generated and spent during a particular quarter, while the other two statements give details about Acura Pharma profits and Acura Pharma debt. Acura Pharma saw a cash impact of $4M from the issuance of ACUR shares. The cash flow statement helps in the Acura Pharma stock analysis by providing more information for evaluating changes in assets, liabilities and equities. Acura Pharma saw a outflow of $- from investing activities till 2017 Q4.

View and download details of Acura Pharma cash flows for latest & last 40 quarters
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow---------
Net Increase (Decrease) in Assets Liabilities-------1.1M-0.56M
Cash From (used in) Discontinued Operations---------
Other Adjustments Net--------1.21M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-----0.07M-0.07M-0.06M-0.04M-0.2M
Acquisition Disposition of Subsidiaires---------
Increase (Decrease) in Investments----10.87M10.87M7.36M3.17M-
Other Cash Inflow (Outflow) from Investment Activities---------
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares4M4M------7.86M
Issuance (Repayment) of Debt Securities-2.76M-1.81M-1.12M-0.44M-2.54M-1.67M-1.03M-0.4M-1.96M
Increase (Decrease) in Bank & Other Borrowings---------
Payment of Dividends & Other Cash Distributions---------
Other Cash from (used by) Financing Activities---------0.61M
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash---------
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year2.48M-12.34M7.47M35.68M24.04M30.17M30.39M31.36M
Cash & Equivalents at Year End2.22M4.78M3.57M6.34M5.18M4.27M3.26M3.28M2.48M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

While Acura Pharma stock price history provides the price history of a stock, Acura Pharma stock comparison chart shows the same in comparison to peers, and cash flow statements provide cash position of the company. Common terms used in the statement of cash flows are:

  • Acura Pharma saw a negative change in Net Change in Cash and Cash Equivalents of $-2.96M till 2017 Q4. Apart from the Acura Pharma stock price, this is one of the things an investor looks for, as it shows the net change in cash on hand for a company, compared to previous period.
  • Acura Pharma decreased its cash from operating activities to $-4.51M till 2017 Q4. Operating activities include production of goods or creating a product or providing a service, and collecting payment for the same from customers. The cash generated from these activities is refered to as cash flow from operating activities.
  • Cash from investing stood at a negative value of $- for ACUR stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Cash Flow from financing activities: The cash inflow/outflow from financing activities was $1.24M for Acura Pharma. The money accounted for under this head comes from external sources which includes lenders, investors and shareholders. Positive cash flow is generated when the company gets cash because of issuance of stocks or bonds. Similarly negative cash flow is generated when shares are repurchased, dividend payments are made, and loans or interest on loans are paid back.

Key Financial Ratios For Acura Pharma Cash Flow